Kiniksa Pharmaceuticals International (KNSA) Price to Sales (2022 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) Price to Sales was 11.86 for Q2 2026, up 53.2% from 7.74 a year earlier and up 20.9% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Price to Sales (2022 - 2026) Analysis & Trends
For FY2025, Price to Sales at Kiniksa Pharmaceuticals International was 9.30, up 37.0% from FY2024.
- By year, Price to Sales came in at 6.79 in FY2024 (-25.8%), 9.16 in FY2023 (-3.5%), 9.49 in FY2022 (-77.5%) and 42.19 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Price to Sales since Q2 2022.
- Year over year, Price to Sales has now increased in each of the last four quarters, with growth averaging 10.5% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was Q2 2026 (growth of 53.2%); the low point was Q1 2023 (a decline of 67.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 9.81 (Q1 2026), 9.30 (Q4 2025) and 9.84 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.86 |
| Mar 31, 2026 | 9.81 |
| Dec 31, 2025 | 9.30 |
| Sep 30, 2025 | 9.84 |
| Jun 30, 2025 | 7.74 |
| Mar 31, 2025 | 6.73 |
| Dec 31, 2024 | 6.79 |
| Sep 30, 2024 | 9.39 |
| Jun 30, 2024 | 7.84 |
| Mar 31, 2024 | 8.98 |
| Dec 31, 2023 | 9.16 |
| Sep 30, 2023 | 9.82 |
| Jun 30, 2023 | 7.04 |
| Mar 31, 2023 | 6.36 |
| Dec 31, 2022 | 9.49 |
| Sep 30, 2022 | 10.09 |
| Jun 30, 2022 | 14.95 |
| Mar 31, 2022 | 19.47 |
API Access
Kiniksa Pharmaceuticals International Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();